Bushen Huatan Formula Combined with Conventional Therapy for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis
Abstract
Introduction: Clinical research suggests that the Bushen Huatan Formula (BHF) may effectively improve polycystic ovary syndrome (PCOS)-related symptoms and infertility. However, no systematic summary of evidence currently exists. This systematic review was designed to assess the therapeutic efficacy and safety profile of BHF when used as a complementary treatment modality for PCOS.
Methods: A systematic search was conducted across multiple databases, including the Cochrane Library, Embase, PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Database, and the China Science and Technology Journal Database (VIP), up to 20 June 2024. Eligible randomized controlled trials (RCTs) included female patients diagnosed with PCOS and compared BHF treatment with conventional biomedical therapies. Results were pooled using random- or fixed-effects models, with effect sizes reported as odds ratios (ORs) or standardized mean differences (SMDs) and their 95% confidence intervals (CIs).
Results: A meta-analysis of 11 RCTs involving 1,006 women with PCOS showed that combining BHF with conventional treatments significantly increased pregnancy rates (OR = 2.58, 95% CI = 1.97 to 3.38, P < 0.01) and ovulation rates (OR = 3.55, 95% CI = 2.29 to 5.48, P < 0.01). It also improved endometrial thickness (SMD = 0.85, 95% CI = 0.39 to 1.31, P < 0.01).
Discussion: BHF had no significant effect on serum levels of total testosterone (T), luteinizing hormone (LH),…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,006 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.